Baxter International Future Growth
Future criteria checks 3/6
Baxter International is forecast to grow earnings and revenue by 35.1% and 3.6% per annum respectively. EPS is expected to grow by 33.6% per annum. Return on equity is forecast to be 16.8% in 3 years.
Key information
35.1%
Earnings growth rate
33.6%
EPS growth rate
Medical Equipment earnings growth | 17.4% |
Revenue growth rate | 3.6% |
Future return on equity | 16.8% |
Analyst coverage | Good |
Last updated | 03 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 16,342 | 1,190 | N/A | 2,066 | 7 |
12/31/2025 | 15,682 | 960 | 1,373 | 2,008 | 14 |
12/31/2024 | 15,107 | 747 | 1,986 | 950 | 14 |
12/31/2023 | 14,813 | -76 | 1,034 | 1,726 | N/A |
9/30/2023 | 15,280 | 225 | 891 | 1,634 | N/A |
6/30/2023 | 15,181 | -2,817 | 829 | 1,559 | N/A |
3/31/2023 | 15,068 | -2,440 | 771 | 1,482 | N/A |
12/31/2022 | 14,506 | -2,666 | 591 | 1,211 | N/A |
9/30/2022 | 14,275 | -2,568 | 792 | 1,465 | N/A |
6/30/2022 | 13,892 | 876 | 1,159 | 1,850 | N/A |
3/31/2022 | 13,396 | 992 | 1,341 | 2,053 | N/A |
12/31/2021 | 12,146 | 1,022 | 1,531 | 2,222 | N/A |
9/30/2021 | 12,451 | 1,214 | 1,496 | 2,241 | N/A |
6/30/2021 | 12,197 | 1,120 | 1,354 | 2,076 | N/A |
3/31/2021 | 11,817 | 1,068 | 1,265 | 1,973 | N/A |
12/31/2020 | 11,673 | 1,102 | 1,159 | 1,868 | N/A |
9/30/2020 | 11,531 | 911 | 1,236 | 1,985 | N/A |
6/30/2020 | 11,410 | 924 | 1,416 | 2,176 | N/A |
3/31/2020 | 11,526 | 991 | 1,487 | 2,248 | N/A |
12/31/2019 | 11,362 | 1,001 | 1,408 | 2,104 | N/A |
9/30/2019 | 11,156 | 1,335 | 1,201 | 1,984 | N/A |
6/30/2019 | 11,066 | 1,484 | 981 | 1,739 | N/A |
3/31/2019 | 11,060 | 1,505 | 929 | 1,698 | N/A |
12/31/2018 | 11,099 | 1,552 | 1,286 | 2,017 | N/A |
9/30/2018 | 11,063 | 1,065 | 1,020 | 1,699 | N/A |
6/30/2018 | 11,009 | 795 | 1,180 | 1,848 | N/A |
3/31/2018 | 10,763 | 840 | 1,409 | 2,095 | N/A |
12/31/2017 | 10,584 | 609 | 1,078 | 1,714 | N/A |
9/30/2017 | 10,432 | 1,025 | N/A | 2,036 | N/A |
6/30/2017 | 10,283 | 904 | N/A | 1,963 | N/A |
3/31/2017 | 10,263 | 1,852 | N/A | 2,176 | N/A |
12/31/2016 | 10,163 | 4,966 | N/A | 1,654 | N/A |
9/30/2016 | 10,121 | 4,909 | N/A | 1,665 | N/A |
6/30/2016 | 10,050 | 4,784 | N/A | 1,388 | N/A |
3/31/2016 | 9,940 | 3,646 | N/A | 1,342 | N/A |
12/31/2015 | 9,968 | 393 | N/A | 1,771 | N/A |
9/30/2015 | 10,154 | 337 | N/A | 2,190 | N/A |
6/30/2015 | 10,376 | 510 | N/A | 2,849 | N/A |
3/31/2015 | 9,274 | 84 | N/A | 2,752 | N/A |
12/31/2014 | 10,719 | 457 | N/A | 3,215 | N/A |
9/30/2014 | 12,252 | 739 | N/A | 3,155 | N/A |
6/30/2014 | 13,253 | 1,092 | N/A | 3,207 | N/A |
3/31/2014 | 15,367 | 1,967 | N/A | 3,371 | N/A |
12/31/2013 | 9,413 | 315 | N/A | 3,198 | N/A |
9/30/2013 | 14,398 | 2,097 | N/A | 3,060 | N/A |
6/30/2013 | 14,165 | 2,152 | N/A | 2,841 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: B1AX34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (9.9%).
Earnings vs Market: B1AX34 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: B1AX34 is expected to become profitable in the next 3 years.
Revenue vs Market: B1AX34's revenue (3.6% per year) is forecast to grow slower than the BR market (7.1% per year).
High Growth Revenue: B1AX34's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: B1AX34's Return on Equity is forecast to be low in 3 years time (16.8%).